What we do

Pawsperity Biotechnologies is improving the current diagnostic toolbox for assessing health and disease in companion animals with innovative, accurate and actionable testing technology, developed through

Molecular profiling

Information gathered at the biomolecular level, from tens of thousands of genes, proteins, metabolites, microbes (see capabilities below)

A.I. & Machine Learning

State-of-the-art data analytics that generate high-resolution health and disease "fingerprints" for each pet, based on its unique molecular profile


Breaking barriers and working across sectors and disciplines to solve problems in veterinary health - together

We are bringing extensive diagnostics development experience from human medicine to animal health, to address some of the most common chronic conditions we share with animals, such as kidney failure, heart disease, and diabetes.

Our capabilities

We have a track record in the analysis of many types of molecular and clinical data, as well as integrating across these diverse data types to generate more informative, biologically-relevant diagnostics


(blood, blood cells, stool, tissue)

Microarrays, next-generation sequencing, targeted gene expression


(blood, tissue, urine)

Mass spectrometry, immuno-assays, other targeted protein assays


(blood, urine)

Nuclear magnetic resonance (NMR), mass spectrometry



DNA methylation arrays (e.g., Illumina EPIC and 450K)

Cell composition

(blood cells, tissue)

Flow cytometry, complete blood counts, single cell sequencing

Imaging & Clinical data

Blood chemistry, physiologic data, treatment, pathology, Imaging (e.g., ultrasound, CT, X-ray),